Best Altcoins to Buy This Month: Rexas Finance, Shiba Inu, and XRP
Ripple’s XRP has returned to investor focus after an all-time high annual candle and increased speculation over a possible ETF launch. Market watchers have associated the ETF rumors with BlackRock, which has intensified institutional interest. These have led to renewed optimism about the future of the token.
The upside of XRP is, however, constrained by its market structure. It must have a market valuation of more than $800 billion to increase to $15. This would make it one of the most valuable assets in the world besides Apple and Bitcoin.
The use of XRP in cross-border payments is still stable. Nevertheless, its full potential will be achieved based on regulatory clarity and general infrastructure development. Although XRP performs well, its short-term development can be moderate because of these structural reasons.
Shiba Inu is Under Supply Pressure: RXS Emerges as Alternative
Shiba Inu (SHIB) has a solid community behind it, but its huge supply of 589 trillion tokens restricts the price growth. The token has lost more than 17% since its May high and is trading below its all-time high.
SHIB would need a market capitalization of over $73 billion to hit $0.000125, which would mark a 10X increase from its current price. This is a major challenge in the current crypto world. Moreover, the recovery path is not clear as more than 85% of SHIB holders are in the loss.
With only 500 million tokens in total supply and over 99% already sold, RXS is preparing for its official exchange launch at $0.25 on June 19, 2025. This limited supply, combined with strong investor interest and a real-world utility model, positions Rexas Finance as one of the most anticipated crypto launches of the year.
Rexas Finance enables the tokenization of real estate, intellectual property, as well as gold. Its ecosystem features tools such as the Rexas QuickMint Bot and Token Builder, allowing users to create tokens with little to no technical expertise. Also, RXS provides staking and farming yield features.
RXS Presale is About to End Before the Exchange Listings
Rexas Finance has collected more than $55 million in presale, and the presale has already sold 99.43% of tokens. The presale will end on June 19, 2025, and RXS will be listed on at least three of the top-tier exchanges with a price of $0.25. To add long-term value, Rexas has also launched its staking pools, allowing users to earn passive rewards and further strengthen the ecosystem.
CertiK has also audited the platform to ensure the security of smart contracts. It also has an AI-based risk management system named Rexas AI Shield that provides real-time fraud detection and prevention. RXS is an Ethereum-based blockchain, and investors can utilize ETH, USDT, or card payments to purchase RXS.
Moreover, Rexas Finance has launched a $1 million giveaway campaign. The investors who invest at least $100 and complete tasks have a chance to win $50,000 in RXS.
Looking ahead, analysts predict that RXS could reach between $10 and $50 within a couple of years. In case the project meets the adoption expectations, market projections point to a long-term price of $100 by 2030.
Conclusion
Three altcoins, XRP, Shiba Inu, and Rexas Finance, are creating a lot of buzz this month. Although XRP and SHIB are still relevant, RXS has solid utility, investor trust, and an exchange launch in the future. As the last presale nears the end, Rexas Finance can be an altcoin to watch in this cycle.
For more details about Rexas Finance (RXS), visit the links below:
Website: https://rexas.com/
Twitter/X: https://x.com/rexasfinance
Telegram: https://t.me/rexasfinance
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance on cryptocurrencies and stocks. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. This article is provided for informational purposes and does not constitute investment advice. You are responsible for conducting your own research (DYOR) before making any investments. Read more about the financial risks involved here.
.png)
